Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases
CDC’s latest emergency use authorization for influenza SARS-CoV-2 assay validates Quantabio’s ability to multiplex up to five targets with high efficiency, sensitivity and specificity BEVERLY, M...
Read More
Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol
Amended CDC emergency use authorization recognizes UltraPlex formulation in an effective heat treatment alternative for RNA extraction BEVERLY, Mass. – July 1, 2020 – Quantabio, a leading provide...
Read More

3 Item(s)